EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Lianxia Xiaopi Granules for Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-Blind and Placebo-Controlled Trial

Yang Yang, Rui Liu, Qiang Zhou, Qing Xia, Yang Gong, Yu-Feng Li, Lu-Zhou Xu, Yan Leng, Bei-Ping Zhang, Zheng-Hua Zhou, Su-Fang Zhou, Tao Zhang und 3 weitere

Chinese Journal of Integrative Medicine · 2026-08 · 32 (8) · 675-684

DOI: 10.1007/s11655-026-3850-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Chinese Journal of Integrative Medicine, online erschienen am 13.05.2026. Verfasst von Yang Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China. Hauptthemen laut MEDLINE: Dyspepsia, Drugs, Chinese Herbal. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the efficacy and safety of Lianxia Xiaopi Granules (LXXP) in treating functional dyspepsia (FD) with combined cold and heat pattern in Chinese medicine (CM). METHODS: A multicenter, randomized, double-blind, and placebo-controlled trial was conducted at 11 centers between April 1, 2021, and October 24, 2022 in China. Using stratified block randomization at a 2:1 ratio, patients diagnosed with FD were randomly assigned to receive either LXXP (3.5 g/bag, equivalent to 8.337 g of raw herbs) or a placebo (3.5 g/bag) 3 times daily for 8 weeks. The primary outcome was dyspepsia symptom response rate. Secondary outcomes included individual dyspepsia symptom response rate, Chinese medicine syndrome efficacy evaluation scale including reduction rate of CM symptom total score, cure and effective rates, and safety analysis. Subgroup analyses were performed according to postprandial distress syndrome (PDS) or epigastric pain syndrome (EPS) subtypes and Helicobacter pylori (Hp) infection status. RESULTS: A total of 240 participants completed the trial, 160 in the LXXP group and 80 in the placebo group. At week 8, the dyspepsia symptom response rate was significantly higher in the LXXP group than in the placebo group [54.38% (87/160) vs. 32.50% (26/80), P=0.0013]. LXXP significantly improved postprandial fullness, early satiety, and bloating compared with the placebo group (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyspepsiaDrugs, Chinese HerbalHumansDouble-Blind MethodFemaleMaleTreatment OutcomeAdultMiddle Aged

Stichwörter der Autor:innen

Helicobacter pyloriChinese medicineLianxia Xiaopi Granulesfunctional dyspepsiapostprandial distress syndromerandomized controlled trial

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
  • Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China.
  • Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Traditional Chinese Medicine, General Hospital of the PLA Northern Theater Command, Shenyang, 110016, China.
  • Department of Gastroenterology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, 110032, China.
  • Department of Gastroenterology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China.

Zitieren

APA

Yang, Y., Liu, R., Zhou, Q., Xia, Q., Gong, Y., Li, Y. F., Xu, L. Z., Leng, Y., Zhang, B. P., Zhou, Z. H., Zhou, S. F., Zhang, T., Liu, S. N., Liu, Y. F., & Feng, P. M. (2026). Lianxia Xiaopi Granules for Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-Blind and Placebo-Controlled Trial. Chinese Journal of Integrative Medicine, 32(8), 675-684. https://doi.org/10.1007/s11655-026-3850-4

Vancouver

Yang Y, Liu R, Zhou Q, Xia Q, Gong Y, Li YF, et al. Lianxia Xiaopi Granules for Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-Blind and Placebo-Controlled Trial. Chinese Journal of Integrative Medicine. 2026;32(8):675-684. doi:10.1007/s11655-026-3850-4

BibTeX
@article{Yang2026,
  author = {Yang, Yang and Liu, Rui and Zhou, Qiang and Xia, Qing and Gong, Yang and Li, Yu-Feng and Xu, Lu-Zhou and Leng, Yan and Zhang, Bei-Ping and Zhou, Zheng-Hua and Zhou, Su-Fang and Zhang, Tao and Liu, Shao-Neng and Liu, Yu-Fei and Feng, Pei-Min},
  title = {Lianxia Xiaopi Granules for Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-Blind and Placebo-Controlled Trial},
  journal = {Chinese Journal of Integrative Medicine},
  year = {2026},
  volume = {32},
  number = {8},
  pages = {675--684},
  doi = {10.1007/s11655-026-3850-4}
}
Kostenlos starten →